# PLEKHF1

## Overview
PLEKHF1 is a gene that encodes the protein pleckstrin homology and FYVE domain containing 1, commonly referred to as Phafin1. This protein is characterized by its structural domains, including a Pleckstrin Homology (PH) domain and a FYVE domain, which are integral to its function in cellular processes such as autophagy and apoptosis. Phafin1 acts as an adaptor protein, facilitating interactions with phosphoinositides and membrane-associated proteins, thereby playing a crucial role in lysosomal targeting and autophagosome formation (Tang2023Phafins; Lin2012Lysosomal). It is involved in the regulation of apoptosis through the recruitment of phosphorylated p53 to lysosomes, leading to lysosomal membrane permeabilization (Tang2024The). The protein is ubiquitously expressed across various human tissues and has been implicated in several diseases, including cancer and idiopathic pulmonary fibrosis, highlighting its potential as a biomarker and therapeutic target (Zhang2022Machine; Tang2024The).

## Structure
Phafin1, encoded by the PLEKHF1 gene, is a protein characterized by its modular structure, which includes an N-terminal Pleckstrin Homology (PH) domain, a central FYVE domain, and a C-terminal tail. The PH domain is a small protein module of 100-120 amino acids, consisting of seven β-strands forming two antiparallel β-sheets capped by a C-terminal α-helix. This domain is involved in binding phosphoinositides, such as PtdIns(3)P, PtdIns(4)P, and PtdIns(5)P, through electrostatic interactions with negatively charged PIP headgroups (Tang2023Phafins).

The FYVE domain is a small, cysteine-rich module that binds specifically to phosphatidylinositol 3-phosphate (PtdIns(3)P). It typically includes two double-stranded β-sheets and a C-terminal α-helix, stabilized by zinc-coordinating cysteines (Tang2023Phafins). The C-terminal tail of Phafin1 is crucial for lysosomal targeting and autophagy induction, providing a unique lysosomal targeting signature (Lin2012Lysosomal).

Phafin1 is involved in apoptosis and autophagy, acting as an adaptor protein that associates with intracellular membranes and recruits binding partners through its PIP-binding domains (Tang2023Phafins). The protein's structure and domain composition enable it to play significant roles in cellular signaling and membrane dynamics.

## Function
PLEKHF1, also known as Phafin1, is a protein that plays a significant role in various cellular processes, including apoptosis and autophagy. It contains pleckstrin homology (PH) and FYVE domains, which are crucial for binding phosphoinositides, specifically phosphatidylinositol 3-phosphate (PtdIns(3)P), and for targeting cellular membranes (Tang2023Phafins; Lin2012Lysosomal). Phafin1 is involved in lysosomal targeting and autophagosome formation, processes mediated by Rab7 signaling. The protein's C-terminal tail is essential for its lysosomal targeting and autophagy induction, as it provides a lysosomal targeting signature and autophagy induction signals (Tang2023Phafins; Lin2012Lysosomal).

Phafin1 also plays a role in apoptosis by recruiting phosphorylated p53 to lysosomes, leading to lysosomal membrane permeabilization and caspase-independent apoptosis (Lin2012Lysosomal; Tang2024The). It is ubiquitously expressed in various human tissues, including fat and spleen, and is involved in endosomal dynamics, influencing cell survival and homeostasis (Tang2023Phafins). Elevated levels of Phafin1 have been observed in various cancers and in the lungs of idiopathic pulmonary fibrosis patients, indicating its potential involvement in disease processes (Tang2024The).

## Clinical Significance
PLEKHF1 has been implicated in several diseases due to its role in cellular processes such as autophagy and apoptosis. In dilated cardiomyopathy (DCM), PLEKHF1 is identified as a key autophagy-related biomarker, suggesting its potential as a diagnostic marker for this condition (Zhang2022Machine). It is also associated with diabetic atherosclerosis and chronic graft-versus-host disease, with clinical validation studies confirming its accuracy as a biomarker (Zhang2022Machine).

In breast cancer, particularly ER-negative grade III types, PLEKHF1 is part of the 19q12 amplicon and is overexpressed when amplified. This overexpression is crucial for the survival of cancer cells with this amplification, indicating its role as a potential driver gene in these cancers (Wilkerson2012the; Natrajan2012Functional). PLEKHF1's interaction with phosphorylated p53 and its role in apoptosis through the lysosomal-mitochondrial pathway further highlight its significance in cancer pathogenesis (Natrajan2012Functional).

In Kawasaki disease, PLEKHF1 is one of the autophagy-related genes with diagnostic value, linked to immune cell infiltration and interactions with CD8+ T cells and neutrophils (Zhu2023Identification). Its expression is also altered in Ankylosing Spondylitis, where it may play a role in the disease's pathogenesis and response to treatment (Chen2023Diagnostic).

## Interactions
PLEKHF1, also known as Phafin1, is involved in several protein interactions that play crucial roles in cellular processes such as autophagy and apoptosis. It contains Pleckstrin Homology (PH) and FYVE domains, which facilitate its binding to phosphoinositides in cellular membranes, allowing it to interact with membrane-associated proteins (Tang2024The).

Phafin1 interacts with Rab7, a key regulator of vesicle trafficking, to mediate lysosomal targeting and autophagosome formation. This interaction is essential for the recruitment of phosphorylated p53 to lysosomes, triggering caspase-independent apoptosis (Lin2012Lysosomal). The tail domain of Phafin1 is critical for its lysosomal targeting, as its deletion prevents lysosomal binding, highlighting the importance of this domain in its interactions (Lin2012Lysosomal).

In the context of apoptosis, Phafin1 is involved in the lysosomal-mitochondrial pathway, where it recruits phosphorylated p53, leading to lysosomal membrane permeabilization and apoptosis (Natrajan2012Functional). These interactions underscore the role of PLEKHF1 in cellular signaling pathways and its potential implications in diseases such as cancer and stress-related disorders (Chitre2023Genomewide; Natrajan2012Functional).


## References


[1. (Tang2024The) Tuoxian Tang, Jing Sun, and Chen Li. The role of phafin proteins in cell signaling pathways and diseases. Open Life Sciences, January 2024. URL: http://dx.doi.org/10.1515/biol-2022-0896, doi:10.1515/biol-2022-0896. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/biol-2022-0896)

[2. (Zhu2023Identification) Hao Zhu, Biao Xu, Cunshu Hu, Aimin Li, and Qing Liao. Identification and validation of autophagy-related genes in kawasaki disease. Hereditas, April 2023. URL: http://dx.doi.org/10.1186/s41065-023-00278-9, doi:10.1186/s41065-023-00278-9. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s41065-023-00278-9)

[3. (Natrajan2012Functional) Rachael Natrajan, Alan Mackay, Paul M Wilkerson, Maryou B Lambros, Daniel Wetterskog, Monica Arnedos, Kai-Keen Shiu, Felipe C Geyer, Anita Langerød, Bas Kreike, Fabien Reyal, Hugo M Horlings, Marc J van de Vijver, Jose Palacios, Britta Weigelt, and Jorge S Reis-Filho. Functional characterization of the 19q12 amplicon in grade iii breast cancers. Breast Cancer Research, March 2012. URL: http://dx.doi.org/10.1186/bcr3154, doi:10.1186/bcr3154. This article has 63 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/bcr3154)

[4. (Chitre2023Genomewide) Apurva S. Chitre, Elaine K. Hebda-Bauer, Peter Blandino, Hannah Bimschleger, Khai-Minh Nguyen, Pamela Maras, Fei Li, A. Bilge Ozel, Yanchao Pan, Oksana Polesskaya, Riyan Cheng, Shelly B. Flagel, Stanley J. Watson, Jun Li, Huda Akil, and Abraham A. Palmer. Genome-wide association study in a rat model of temperament identifies multiple loci for exploratory locomotion and anxiety-like traits. Frontiers in Genetics, January 2023. URL: http://dx.doi.org/10.3389/fgene.2022.1003074, doi:10.3389/fgene.2022.1003074. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1003074)

[5. (Lin2012Lysosomal) Wen-Jie Lin, Chih-Yung Yang, Li-Li Li, Yung-Hsiang Yi, Ke-Wei Chen, Ying-Chih Lin, Chin-Chun Liu, and Chi-Hung Lin. Lysosomal targeting of phafin1 mediated by rab7 induces autophagosome formation. Biochemical and Biophysical Research Communications, 417(1):35–42, January 2012. URL: http://dx.doi.org/10.1016/j.bbrc.2011.11.043, doi:10.1016/j.bbrc.2011.11.043. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2011.11.043)

[6. (Zhang2022Machine) Fengjun Zhang, Mingyue Xia, Jiarong Jiang, Shuai Wang, Qiong Zhao, Cheng Yu, Jinzhen Yu, Dexian Xian, Xiao Li, Lin Zhang, Yuan Liu, and Min Peng. Machine learning and bioinformatics to identify 8 autophagy-related biomarkers and construct gene regulatory networks in dilated cardiomyopathy. Scientific Reports, September 2022. URL: http://dx.doi.org/10.1038/s41598-022-19027-5, doi:10.1038/s41598-022-19027-5. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-19027-5)

[7. (Wilkerson2012the) Paul M. Wilkerson and Jorge S. Reis‐Filho. The 11q13‐q14 amplicon: clinicopathological correlations and potential drivers. Genes, Chromosomes and Cancer, 52(4):333–355, December 2012. URL: http://dx.doi.org/10.1002/gcc.22037, doi:10.1002/gcc.22037. This article has 53 citations.](https://doi.org/10.1002/gcc.22037)

[8. (Tang2023Phafins) Tuoxian Tang, Mahmudul Hasan, and Daniel G. S. Capelluto. Phafins are more than phosphoinositide-binding proteins. International Journal of Molecular Sciences, 24(9):8096, April 2023. URL: http://dx.doi.org/10.3390/ijms24098096, doi:10.3390/ijms24098096. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24098096)

9. (Chen2023Diagnostic) Diagnostic biomarkers and potential treatment targets for Ankylosing Spondylitis. This article has 0 citations.